Ondansetron Injection
Product Images NDC 0641-6078

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 0641-6078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ondansetron Injection Usp 1)

Chemical structure of Ondansetron, depicted as a complex molecular diagram including a bicyclic ring and imidazole group, labeled with hydrochloride dihydrate (HCl·2H2O).*

FDA Label Image

Ondansetron Injection, Usp 4 mg/2 mL (2 mg/ml) 2 mL Single Dose Vial (Ondansetron Injection Usp 2)

Ondansetron Injection USP 4 mg per 2 mL (2 mg/mL) label for injection, indicating administration by intravenous or intramuscular route. The label shows a 2 mL single dose vial, manufactured by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. It includes storage instructions to protect from light and has space for lot number and expiration date.*

FDA Label Image

Ondansetron Injection, Usp 4 mg/2 mL (2 mg/ml) 25 X 2 mL Single Dose Vials (Ondansetron Injection Usp 3)

Ondansetron Injection, USP 4 mg per 2 mL (2 mg/mL) sterile solution for intravenous or intramuscular injection. The label shows it comes in 25 single dose vials of 2 mL each. Manufactured by Hikma Pharmaceuticals USA Inc. Storage instructions and formulation details are also provided on the label.*

FDA Label Image

Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) 20 mL Multiple Dose Vial (Ondansetron Injection Usp 4)

Label for Ondansetron Injection, USP 2 mg/mL (40 mg per 20 mL) multiple dose vial, for intravenous or intramuscular injection. The label includes storage instructions, manufacturer details (Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ), and mentions the vial contains aqueous solution with preservatives and buffers.*

FDA Label Image

Ondansetron Injection, Usp 40 mg/20 mL (2 mg/ml) 20 mL Multiple Dose Vial (Ondansetron Injection Usp 5)

Packaging label for Ondansetron Injection, USP 40 mg per 20 mL (2 mg/mL) for intravenous or intramuscular injection. The sterile liquid is contained in a 20 mL multiple-dose vial. Labeler is Hikma Pharmaceuticals USA Inc. The label includes storage and preservative information, a barcode, and the product NDC 0641-6079-01.*

FDA Label Image

Ondansetron Injection Usp 6

Ondansetron 2 mg/mL injection label showing a QR code and printed identifiers including GTIN, serial number, expiration date, and lot number. The label indicates use by Hikma Pharmaceuticals USA Inc. for intramuscular or intravenous administration.*

FDA Label Image

Ondansetron Injection Usp 7

A label showing a QR code alongside printed text including lot number, expiration date, GTIN barcode number, and serial number. The label is associated with Ondansetron injection 2 mg/mL by Hikma Pharmaceuticals USA Inc., intended for intramuscular or intravenous use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.